[HTML][HTML] Deferiprone: a forty-year-old multi-targeting drug with possible activity against COVID-19 and diseases of similar symptomatology
GJ Kontoghiorghes - International Journal of Molecular Sciences, 2022 - mdpi.com
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
Deferiprone: a forty-year-old multi-targeting drug with possible activity against COVID-19 and diseases of similar symptomatology.
GJ Kontoghiorghes - 2022 - cabidigitallibrary.org
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.
GJ Kontoghiorghes - International Journal of Molecular …, 2022 - search.ebscohost.com
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.
GJ Kontoghiorghes - International Journal of Molecular Sciences, 2022 - europepmc.org
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
[HTML][HTML] Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology
GJ Kontoghiorghes - International Journal of Molecular Sciences, 2022 - ncbi.nlm.nih.gov
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology
GJ Kontoghiorghes - International Journal of Molecular …, 2022 - search.proquest.com
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology
GJ Kontoghiorghes - 2022 - agris.fao.org
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology
GJ Kontoghiorghes - International journal of molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …